Jessica J. Kandel to Female
This is a "connection" page, showing publications Jessica J. Kandel has written about Female.
Connection Strength
0.282
-
Image-guided esophageal anastomosis in esophageal atresia. J Pediatr Surg. 2012 Oct; 47(10):1959-61.
Score: 0.021
-
Severe Mycoplasma pneumoniae infection requiring extracorporeal membrane oxygenation with concomitant ischemic stroke in a child. Pediatr Pulmonol. 2013 Jan; 48(1):98-101.
Score: 0.021
-
Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade. Int J Oncol. 2009 Jan; 34(1):79-87.
Score: 0.017
-
Ovarian repositioning in pediatric cancer patients: Flexible techniques accommodate pelvic radiation fields. Pediatr Blood Cancer. 2007 Sep; 49(3):339-41.
Score: 0.015
-
Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature. Int J Oncol. 2004 Sep; 25(3):549-53.
Score: 0.012
-
Vascular remodeling marks tumors that recur during chronic suppression of angiogenesis. Mol Cancer Res. 2004 Jan; 2(1):36-42.
Score: 0.012
-
Human epidermal growth factor receptor signaling contributes to tumor growth via angiogenesis in her2/neu-expressing experimental Wilms' tumor. J Pediatr Surg. 2003 Nov; 38(11):1569-73.
Score: 0.012
-
Blockade of her2/neu decreases VEGF expression but does not alter HIF-1 distribution in experimental Wilms tumor. Oncol Rep. 2003 Sep-Oct; 10(5):1271-4.
Score: 0.011
-
Histotripsy induces apoptosis and reduces hypoxia in a neuroblastoma xenograft model. Int J Hyperthermia. 2023; 40(1):2222941.
Score: 0.011
-
Resistance of a VEGF-producing tumor to anti-VEGF antibody: unimpeded growth of human rhabdoid tumor xenografts. J Pediatr Surg. 2002 Mar; 37(3):528-32.
Score: 0.010
-
Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor. J Pediatr Surg. 2001 Dec; 36(12):1781-4.
Score: 0.010
-
Effective therapy of a vascular tumor of infancy with vincristine. J Pediatr Surg. 2001 Aug; 36(8):1273-6.
Score: 0.010
-
Suppression of primary tumor growth in a mouse model of human neuroblastoma. J Pediatr Surg. 2000 Jun; 35(6):977-81.
Score: 0.009
-
Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor. J Pediatr Surg. 2000 Jan; 35(1):30-2; discussion 32-3.
Score: 0.009
-
Metastasis correlates with production of vascular endothelial growth factor in a murine model of human Wilms' tumor. J Pediatr Surg. 1999 May; 34(5):743-7; discussion 747-8.
Score: 0.008
-
Evaluation of a water-soluble contrast protocol for nonoperative management of pediatric adhesive small bowel obstruction. J Pediatr Surg. 2019 Jan; 54(1):184-188.
Score: 0.008
-
A metastasizing model of anaplastic human Wilms tumor in the nude mouse. Eur J Pediatr Surg. 1998 Oct; 8(5):295-8.
Score: 0.008
-
Initial Experience With Propranolol Treatment of Lymphatic Anomalies: A Case Series. Pediatrics. 2016 09; 138(3).
Score: 0.007
-
Notch suppresses angiogenesis and progression of hepatic metastases. Cancer Res. 2015 Apr 15; 75(8):1592-602.
Score: 0.006
-
Clinical spectrum of capillary malformation-arteriovenous malformation syndrome presenting to a pediatric dermatology practice: a retrospective study. Pediatr Dermatol. 2015 Jan-Feb; 32(1):76-84.
Score: 0.006
-
Ultrasonography/MRI versus CT for diagnosing appendicitis. Pediatrics. 2014 Apr; 133(4):586-93.
Score: 0.006
-
Congenital cutaneous hemangioma causing cardiac failure: a case report and review of the literature. Pediatr Dermatol. 2013 Nov-Dec; 30(6):e180-90.
Score: 0.005
-
Monitoring early tumor response to drug therapy with diffuse optical tomography. J Biomed Opt. 2012 Jan; 17(1):016014.
Score: 0.005
-
Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors. J Control Release. 2012 Jan 30; 157(2):224-34.
Score: 0.005
-
Neonatal hepatic mesenchymal hamartoma causing cardiac failure and disseminated intravascular coagulopathy. Am J Perinatol. 2009 Sep; 26(8):601-4.
Score: 0.004
-
Vascular endothelial growth factor blockade rapidly elicits alternative proangiogenic pathways in neuroblastoma. Int J Oncol. 2009 Feb; 34(2):401-7.
Score: 0.004
-
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2008 Jan 20; 26(3):399-405.
Score: 0.004
-
Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation. Mol Cancer Res. 2008 Jan; 6(1):1-9.
Score: 0.004
-
Multiple cutaneous infantile hemangiomas associated with hepatic angiosarcoma: case report and review of the literature. Pediatrics. 2006 Sep; 118(3):e907-13.
Score: 0.003
-
Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling. Cancer Res. 2006 Apr 15; 66(8):4378-84.
Score: 0.003
-
Preoperative angiography with embolization and radiofrequency ablation as novel adjuncts to safe surgical resection of a large, vascular sacrococcygeal teratoma. Pediatr Surg Int. 2006 Jun; 22(6):554-6.
Score: 0.003
-
Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis. J Pediatr Surg. 2003 Mar; 38(3):308-14; discussion 308-14.
Score: 0.003
-
Topotecan is anti-angiogenic in experimental hepatoblastoma. J Pediatr Surg. 2002 Jun; 37(6):857-61.
Score: 0.003
-
Distinct response of experimental neuroblastoma to combination antiangiogenic strategies. J Pediatr Surg. 2002 Mar; 37(3):518-22.
Score: 0.003
-
Quasielastic light scattering study of the living human lens as a function of age. Curr Eye Res. 1997 Mar; 16(3):197-207.
Score: 0.002